In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH National Library of Medicine Training Grant
Grant: T15LM011271
The Mark Foundation for Cancer Research
Grant: 18-022-ELA
Canadian Institute for Advanced Research
Grant: FL-000655
NIH NCI
Grant: RO1 CA220009
NCI NIH HHS
Grant: R01 CA220009
FWCI
0.43
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals